Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New dopamine/serotonin receptor agonists imparted in recent Atir patent

Nov. 6, 2008

Sanofi-aventis discontinues rimonabant clinical development

Nov. 6, 2008

Recent Kowa patent reports novel therapeutic agents for lipoprotein disorders

Nov. 6, 2008

FDA approves Norditropin for children born small for gestational age

Nov. 6, 2008

HemaQuest receives orphan drug status for HQK-1001 for hemoglobin disorders

Nov. 5, 2008

Biotec initiates enrollment in second phase III study of SBG for diabetic ulcers

Nov. 5, 2008

Halozyme initiates phase II trial of insulin with rHuPH20 in type 1 diabetes

Nov. 5, 2008

BioMarin commences clinical assessment program for Morquio A syndrome

Nov. 4, 2008

Savient submits BLA to FDA for pegloticase

Nov. 3, 2008

Bayhill and Juvenile Diabetes Research Foundation enter research collaboration

Nov. 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...